* The FreeStyle Libre 2 app is only compatible with certain mobile devices and operating systems. Please check the Compatibility Guide (PDF 69 KB) for more information about device compatibility before using the app. Use of FreeStyle Libre 2 may require registration with LibreView.

† Based on the number of users worldwide for the FreeStyle Libre system compared to the number of users for other leading personal-use sensor-based glucose monitoring systems.

‡ Based on a comparison to Dexcom G6.

§ Notifications will only be received when alarms are turned on and the sensor is within 20 feet unobstructed of the reading device. You must enable the appropriate settings on your smartphone to receive alarms and alerts; see the FreeStyle Libre 2 User’s Manual for more information.

¶ The FreeStyle Libre 2 app and the FreeStyle Libre 2 reader have similar but not identical features. Finger pricks are required if glucose readings and alarms do not match symptoms or expectations. The FreeStyle Libre 2 sensor communicates with the FreeStyle Libre 2 reader that started it or the FreeStyle Libre 2 app that started it. The FreeStyle Libre 2 app is only compatible with certain mobile devices and operating systems. Please check the Compatibility Guide (PDF 69 KB) for more information about device compatibility before using the app. Use of FreeStyle Libre 2 may require registration with LibreView.

** The FreeStyle LibreLink app and the FreeStyle Libre reader have similar but not identical features. A finger prick test using a blood glucose meter is required during times of rapidly changing glucose levels when interstitial fluid glucose levels may not accurately reflect blood glucose levels or if hypoglycemia or impending hypoglycemia is reported by the FreeStyle LibreLink app or when symptoms do not match the app readings. The FreeStyle Libre sensor communicates with the FreeStyle Libre reader that started it or the FreeStyle LibreLink app that started it. A sensor started by the FreeStyle Libre reader will also communicate with the FreeStyle LibreLink app. The FreeStyle LibreLink app is only compatible with certain mobile devices and operating systems. Please check the Compatibility Guide (PDF 69 KB) for more information about device compatibility before using the app. Use of FreeStyle LibreLink may require registration with LibreView.

†† For people managing diabetes with insulin.

‡‡ To be eligible for FreeStyle Libre 2 reimbursement in Quebec, criteria are as follows: under the age of 18 and living with type 1 diabetes; over the age of 18, living with diabetes and meets the following two criteria: is on intensive insulin therapy (insulin pump treatment or ≥3 insulin injections per day), and has frequent hypoglycemic events during the last year, despite adherence to a blood sugar management plan.

§§ The FreeStyle Libre 2 system is covered under the Saskatchewan government-sponsored drug plan for those between the ages of 4 and 17 who manage their diabetes with insulin or have hyperinsulinism.

¶¶ For patients living with type 1 or type 2 diabetes, who are currently on both basal and bolus insulin or using an insulin pump.

*** Those eligible for reimbursement in Prince Edward Island must be 4 years of age or older, be taking three or more daily injections of insulin or using an insulin pump, and must be enrolled in the Diabetes Glucose Sensor Program.

††† For people over 4 years of age with Type 1 Diabetes.

‡‡‡ BC Residents 4 years of age or older living with diabetes, who require multiple daily injections, or insulin pump therapy, and have one of the following symptoms: hypoglycemia unawareness, frequent and unpredictable hypoglycemic episodes, unpredictable swings in blood glucose, at least one functional restriction that inhibits the use of blood glucose test strips, an occupation where hypoglycemia presents a significant safety risk.

§§§ FreeStyle Libre 2 system (reader and sensors) is a limited use benefit for individuals who are currently managing their diabetes with insulin.

¶¶¶ Sensors are available for eligible patients who meet the labelling requirements of 4 years or older with diabetes. Limit: one per registrant.

References:

1. Fokkert M, et al. Improved well-being and decreased disease burden after 1-year use of flash glucose monitoring (FLARE-NL4). BMJ Open Diabetes Res Care 2019;7(1):e000809. https://doi.org/10.1136/bmjdrc-2019-000809.
2. Data on file, Abbott Diabetes Care Inc.
3. FreeStyle Libre 2 User’s Manual.